B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

XPO1

MOLECULAR TARGET

exportin 1

UniProt: O14980NCBI Gene: 75145 compounds

XPO1 (exportin 1) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting XPO1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1zafirlukast3.8948
2osthole3.4029
3as 6028682.5612
4plumbagin [Supplementary Concept]1.102
5oridonin1.102

About XPO1 as a Drug Target

XPO1 (exportin 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented XPO1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

XPO1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.